Frequency of Aspirin Resistance in a Community Hospital

American Journal of Cardiology

Volumn 98, Issue 5, 2006, Pages 577-579

  Mirkhel, Ahmadshah ^a   Peyster, Eliot ^b   Sundeen, James ^a   Greene, Linda ^a   Michelson, Alan D ^c   Hasan, Ahmed ^b   Domanski, Michael ^b  

^a Prince Georges Hospital Center   (United States)

^b NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

^c UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTITHROMBOCYTIC AGENT; CLOPIDOGREL;

ADULT; AGED; ARTICLE; COMMUNITY HOSPITAL; CONFIDENCE INTERVAL; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DEMOGRAPHY; DOSE RESPONSE; FEMALE; HUMAN; HYPERTENSION; INFORMATION PROCESSING; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PREDICTION; PRIORITY JOURNAL; SMOKING; STATISTICAL SIGNIFICANCE; THROMBOSIS; THROMBOSIS PREVENTION;

ADULT; AGED; AGED, 80 AND OVER; ASPIRIN; DRUG RESISTANCE; FEMALE; HOSPITALS, COMMUNITY; HUMANS; INCIDENCE; MALE; MARYLAND; MIDDLE AGED; PLATELET AGGREGATION INHIBITORS; PROGNOSIS; RETROSPECTIVE STUDIES; THROMBOSIS;

EID: 33747157718     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjcard.2006.03.029     Document Type: Article

References (15)

1. Antithrombotic Trialists' Collaboration. Collaborative meta-analysis of randomized trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients. BMJ 324 (2002) 71-86
2. Eikelboom J., and Hankley G. Aspirin resistance. a new independent predictor of vascular events. J Am Coll Cardiol 41 (2003) 966-968
3. Grotemeyer K.H., Scharafinski H.W., and Husstedt I.W. Two-year follow-up of aspirin responder and aspirin non-responder. A pilot study including 180 post-stroke patients. Thromb Res 71 (1993) 397-403
4. Mueller M.R., Salat A., Stangl P., Murabito M., Pulaki S., Boehm D., Koppensteiner R., Ergun E., Mittlboeck M., Schreiner W., et al. Variable platelet response to low-dose aspirin and the risk of limb deterioration in patients submitted to peripheral arterial angioplasty. Thromb Haemost 78 (1997) 1003-1007
5. Eikelboom J.W., Hirsh J., Weitz J.I., Johnston M., Yi Q., and Yusuf S. Aspirin-resistant thromboxane biosynthesis and the risk of myocardial infarction, stroke, or cardiovascular death in patients at high risk for cardiovascular events. Circulation 105 (2002) 1650-1655
6. Gum P.A., Kottke-Marchant K., Welsh P.A., White J., and Topol E.J. A prospective, blinded determination of the natural history of aspirin resistance among stable patients with cardiovascular disease. J Am Coll Cardiol 41 (2003) 961-965
7. Chen W., Lee P., Ng W., Tse H., and Lau C. Aspirin resistance is associated with a high incidence of myonecrosis after non-urgent percutaneous coronary intervention despite clopidogrel pretreatment. J Am Coll Cardiol 43 (2004) 1122-1126
8. McKenna R., Galante J., Bachmann F., Wallace D.L., Kaushal P.S., and Meredith P. Prevention of venous thrombo-embolism after total knee replacement by high-dose aspirin or intermittent calf and thigh compression. BMJ 280 (1980) 514-517
9. Harris W.H., Athanasoulis C.A., Waltman A.C., and Salzman E.W. High and low-dose aspirin prophylaxis against venous thromboembolic disease in total hip replacement. J Bone Joint Surg 64 (1982) 63-66
10. Harris W.H., Athanasoulis C.A., Waltman A.C., and Salzman E.W. Prophylaxis of deep vein thrombosis after total hip replacement. dextran and external compression compared with 1.2 or 0.3 gram of aspirin daily. J Bone Joint Surg 67 (1985) 57-62
11. Farrell B., Godwin J., Richards S., and Warlow C. The United Kingdom transient ischaemic attack (UK-TIA) aspirin trial. final results. J Neurol Neurosurg Psychiatry 54 (1991) 1044-1054
12. Dutch TIA Trial Study Group. A comparison of two doses of aspirin (30 mg vs 283 mg a day) in patients after a transient ischemic attack or minor ischemic stroke. N Engl J Med 325 (1991) 1261-1266
13. Taylor D.W., Barnett H.J., Haynes R.B., Ferguson G.G., Sackett D.L., Thorpe K.E., Simard D., Silver F.L., Hachinski V., Clagett G.P., et al. Low-dose and high-dose acetylsalicylic acid for patients undergoing carotid endarterectomy. a randomised controlled trial. Lancet 353 (1999) 2179-2184
14. Levine P.H. An acute effect of cigarette smoking on platelet function. A possible link between smoking and arterial thrombosis. Circulation 48 (1973) 619-623
15. Pulcinelli F., Pignatelli P., Celetini A., Riondino S., Gazzaniga P., and Violi F. Inhibition of platelet aggregation by aspirin progressively decreases in long-term treated patients. J Am Coll Cardiol 43 (2004) 979-984